微結晶セルロース（MCC）市場：原料タイプ、用途、エンドユーザー、地域別、2026年～2032年

微結晶セルロース（MCC）市場の評価、2026年～2032年

微結晶セルロース（MCC）市場は、特に医薬品、食品、化粧品など、様々な産業における多目的な用途により、需要が大幅に増加しています。医薬品製剤の重要な賦形剤として、MCCは錠剤やカプセルの有効性を高める優れた結合、崩壊、流動特性で評価されています。ヘルスケア支出の増加や慢性疾患の有病率の上昇を背景とした世界の製薬業界の成長が、MCCの需要を押し上げています。市場規模は2024年に13億8,000万米ドルを突破し、2032年には約24億6,000万米ドルに達します。

食品業界は、低カロリー製品やグルテンフリー製品の脂肪代替剤や安定剤としてMCCを採用し、市場成長にさらに貢献しています。費用対効果が高く効率的な感情分析に対する需要の高まりが、2026年から2032年までのCAGR 8.24%での市場成長を可能にしています。

微結晶セルロース（MCC）市場：定義/概要

微結晶セルロース（MCC）は、植物セルロース源から加水分解によって得られる、精製された部分解重合セルロースです。白色で無臭の粉末であり、高純度、低密度、優れた流動性などのユニークな特性を有します。MCCは、充填剤、結合剤、安定剤として医薬品、食品、化粧品産業で広く利用されています。医薬品では、錠剤の賦形剤として圧縮性を高め、薬物の放出を助ける。食品産業では、テクスチャリング剤、脂肪代替剤、増量剤として機能し、様々な製品の一貫性と安定性に貢献します。

微結晶セルロースは、さまざまな分野で天然素材や持続可能な素材への需要が高まっていることを背景に、有望視されています。健康と栄養に関する消費者の意識が高まる中、MCCの用途はクリーンラベル製品の処方において拡大する可能性が高いです。ナノテクノロジーの革新により、MCCベースのナノ複合材料が開発され、包装やドラッグデリバリーシステムなどの用途で機能性が向上する可能性があります。バイオテクノロジーの進歩により、再生可能な代替資源からMCCを生産することが可能になり、環境に優しい原料としての役割がさらに強固なものになる可能性があります。産業界が環境への影響を最小限に抑えようとする中、MCCの生分解性と再生可能な特性は、健康、食品、材料科学の分野における将来の用途にとって価値ある材料として位置づけられています。

成長する医薬品産業は微結晶セルロース（MCC）市場を牽引するか？

成長する製薬業界は、微結晶セルロース（MCC）市場に大きな燃料を供給することになると思われます。製薬部門はMCCの主要な消費者であり、さまざまな医薬品製剤の賦形剤としてMCCを利用しているため、医薬品への世界の支出は2026年までに1兆8,000億米ドルに達すると予測され、CAGRは3～6%になると予想されています。このような医薬品への投資の増加は、錠剤の圧縮性、安定性、バイオアベイラビリティの向上に不可欠な役割を果たすMCCの需要を促進するだけでなく、新しく革新的なドラッグデリバリー・システムの開発における高品質の賦形剤の必要性を浮き彫りにしています。

加工食品や簡便食品への需要の高まりは、微結晶セルロース（MCC）市場を大きく刺激します。消費者が手早く簡単に調理できる食事の選択肢を求める中、世界のコンビニエンス・フード市場は2021年に5,137億米ドル規模に達し、2022年から2030年にかけてCAGR 5.6%で成長すると予測され、急速に拡大しています。食感改良剤および脂肪代替剤としてのMCCの役割は、加工食品の食感と安定性を高める貴重な添加物であり、品質に妥協することなく、より健康的で低脂肪の選択肢を求める消費者の嗜好に応えるものです。利便性の高い食品への志向の高まりは、食品配合におけるMCCの利用の増加と直結しており、食品業界におけるこの万能成分の需要を全体的に押し上げています。

原材料の入手可能性は微結晶セルロース（MCC）市場の成長に影響を与えるか？

原材料の入手可能性は、微結晶セルロース（MCC）市場の成長を妨げる可能性があります。MCCは主に木材パルプや植物繊維などの天然セルロース源から得られるが、気候変動、森林伐採、これらの原料をめぐる他産業との競合などの要因により、入手可能性が変動する可能性があります。持続可能な慣行に対する需要の高まりは、生産者が環境に優しい調達と生産方法にますます重点を置くようになっているため、高品質のセルロースの供給に負担をかける可能性があります。

食品・医薬品業界は添加物の使用に関して厳しい規制を受けているため、規制上のハードルが微結晶セルロース（MCC）市場の成長を妨げる可能性があります。こうした規制は、しばしば広範な安全性と有効性の評価を必要とするため、製品承認にかかるコストの増大や期間の長期化につながる可能性があります。MCCを世界規模で販売しようとするメーカーにとっては、地域によって規制基準が異なることが課題となっており、コンプライアンスへの取り組みが複雑になっています。天然志向やクリーンラベル製品の動向は、規制当局がMCCのような安全で効果的な天然添加物を受け入れるよう枠組みを適応させることを後押しする可能性があり、その結果、MCCが受け入れられやすくなり、用途の革新が促進される可能性があります。

目次

第1章 イントロダクション

• 市場の定義
• 市場セグメンテーション
• 調査手法

第2章 エグゼクティブサマリー

• 主な調査結果
• 市場概要
• 市場ハイライト

第3章 市場概要

• 市場規模と成長の可能性
• 市場動向
• 市場促進要因
• 市場抑制要因
• 市場機会
• ポーターのファイブフォース分析

第4章 微結晶セルロース（MCC）市場：原料タイプ別

• 非木材ベースMCC
• 木材ベースMCC

第5章 微結晶セルロース（MCC）市場：用途別

• 化粧品とパーソナルケア
• 飲食品
• 医薬品

第6章 微結晶セルロース（MCC）市場：エンドユーザー別

• 化粧品・パーソナルケア産業
• 飲食品産業
• 製薬業界

第7章 地域別分析

• 北米
• 米国
• カナダ
• メキシコ
• 欧州
• 英国
• ドイツ
• フランス
• イタリア
• アジア太平洋
• 中国
• 日本
• インド
• オーストラリア
• ラテンアメリカ
• ブラジル
• アルゼンチン
• チリ
• 中東・アフリカ
• 南アフリカ
• サウジアラビア
• アラブ首長国連邦

第8章 市場力学

• 市場促進要因
• 市場抑制要因
• 市場機会
• COVID-19の市場への影響

第9章 競合情勢

• 主要企業
• 市場シェア分析

第10章 企業プロファイル

• Wei Ming Pharmaceutical Co., Ltd.（China）
• Juku Orchem Private Limited（India）
• Sigachi（Japan）
• BLANVER（China）
• Anhui Sunhere Pharmaceutical Group Co., Ltd.（China）
• Roquette Freres（France）
• DuPont de Nemours, Inc.（US）
• Ashland Global Holdings Inc.（US）
• Borregaard ASA（Norway）
• Imerys S.A.（France）

第11章 市場の展望と機会

• 新興技術
• 今後の市場動向
• 投資機会

第12章 付録

• 略語リスト
• 出典と参考文献

Microcrystalline Cellulose Market Valuation - 2026-2032

The microcrystalline cellulose (MCC) market is experiencing a significant increase in demand due to its versatile applications across various industries, particularly in pharmaceuticals, food, and cosmetics. As a crucial excipient in drug formulations, MCC is valued for its excellent binding, disintegration, and flow properties, which enhance the efficacy of tablets and capsules. The growing global pharmaceutical industry, driven by an increase in healthcare spending and the rising prevalence of chronic diseases, is propelling the demand for MCC. The market size surpass USD 1.38 Billion valued in 2024 to reach a valuation of around USD 2.46 Billion by 2032.

The food industry is embracing MCC as a fat replacer and a stabilizer in low-calorie and gluten-free products, further contributing to its market growth. The rising demand for cost-effective and efficient emotion analytics is enabling the market grow at a CAGR of 8.24% from 2026 to 2032.

Microcrystalline Cellulose Market: Definition/ Overview

Microcrystalline cellulose (MCC) is a purified, partially depolymerized cellulose obtained from plant cellulose sources through hydrolysis. It appears as a white, odorless powder and possesses unique properties such as high purity, low density, and excellent flowability. MCC is widely utilized in the pharmaceutical, food, and cosmetic industries as a filler, binder, and stabilizer. In pharmaceuticals, it serves as an excipient in tablet formulations, enhancing compressibility and aiding in drug release. In the food industry, it acts as a texturizing agent, fat replacer, and bulking agent, contributing to the consistency and stability of various products.

Microcrystalline cellulose looks promising, driven by the growing demand for natural and sustainable ingredients in various sectors. With increasing consumer awareness regarding health and nutrition, MCC's applications are likely to expand in the formulation of clean-label products. Innovations in nanotechnology may lead to the development of MCC-based nanocomposites, enhancing their functionality in applications like packaging and drug delivery systems. Advancements in biotechnology may enable the production of MCC from alternative, renewable sources, further solidifying its role as an eco-friendly ingredient. As industries seek to minimize their environmental impact, MCC's biodegradable and renewable characteristics position it as a valuable material for future applications in health, food, and materials science.

Will the Growing Pharmaceutical Industry Drive the Microcrystalline Cellulose Market?

The growing pharmaceutical industry is set to significantly fuel the microcrystalline cellulose (MCC) market. As the pharmaceutical sector is a major consumer of MCC, utilizing it as an excipient in various drug formulations, the projected global spending on medicines-expected to reach $1.8 trillion by 2026 with a compound annual growth rate (CAGR) of 3-6%-indicates a robust growth trajectory for the industry. This increasing investment in pharmaceuticals not only drives demand for MCC due to its essential roles in enhancing tablet compressibility, stability, and bioavailability but also highlights the need for high-quality excipients in the development of new and innovative drug delivery systems.

The increasing demand for processed and convenience foods will significantly fuel the microcrystalline cellulose (MCC) market. As consumers seek quick, easy-to-prepare meal options, the global convenience food market, valued at $513.7 billion in 2021 and projected to grow at a CAGR of 5.6% from 2022 to 2030, is expanding rapidly. MCC's role as a texturizing agent and fat replacer makes it a valuable additive in enhancing the texture and stability of processed foods, catering to consumer preferences for healthier, lower-fat options without compromising on quality. This growing inclination towards convenience foods directly correlates with the increased utilization of MCC in food formulations, driving the overall demand for this versatile ingredient in the food industry.

Will Raw Material Availability Impact the Growth of the Microcrystalline Cellulose Market?

Raw material availability could potentially hamper the growth of the microcrystalline cellulose (MCC) market. MCC is primarily derived from natural cellulose sources, such as wood pulp and plant fibers, which are subject to fluctuations in availability due to factors like climate change, deforestation, and competition with other industries for these raw materials. The rising demand for sustainable practices may strain the supply of high-quality cellulose, as producers increasingly focus on eco-friendly sourcing and production methods.

Regulatory hurdles may hamper the growth of the microcrystalline cellulose (MCC) market, as the food and pharmaceutical industries are subject to stringent regulations regarding the use of additives. These regulations often require extensive safety and efficacy evaluations, which can lead to increased costs and extended timelines for product approvals. Varying regulatory standards across different regions can create challenges for manufacturers looking to market MCC globally, complicating compliance efforts, the trend towards natural and clean-label products may push regulatory bodies to adapt their frameworks to accommodate safe and effective natural additives like MCC, potentially facilitating its acceptance and encouraging innovation in its applications.

Category-Wise Acumens

Will High Purity and Consistency Propel the Non-Wood Based MCC Segment for the Microcrystalline Cellulose Market?

Non-Wood Based MCC Segment is dominating the microcrystalline cellulose market. High purity and consistency are key factors propelling the non-wood-based microcrystalline cellulose (MCC) segment in the microcrystalline cellulose market. As industries increasingly prioritize quality and safety, the demand for MCC with high purity levels becomes critical, especially in pharmaceuticals, food, and cosmetics, where contaminants can significantly impact product efficacy and consumer safety. Non-wood sources, such as cotton and certain plant fibers, offer a more consistent and controllable production process, resulting in a higher-quality end product. This consistency enhances the reliability of MCC in applications requiring precise formulations, thus driving growth in this segment.

Versatility is likely to propel the non-wood-based microcrystalline cellulose (MCC) segment in the microcrystalline cellulose market. This segment benefits from the ability to source MCC from various alternative raw materials, such as agricultural residues and non-wood plants, which can offer unique properties and functionalities tailored to specific applications in food, pharmaceuticals, and cosmetics. The growing demand for sustainable and eco-friendly products is driving manufacturers to seek alternatives to traditional wood-based sources, which are often associated with deforestation and environmental concerns.

Will Innovative Drug Development Boost the Pharmaceuticals Segment for the Microcrystalline Cellulose Market?

The pharmaceutical segment is dominating the microcrystalline cellulose market. Innovative drug development is expected to significantly promote the pharmaceuticals segment of the microcrystalline cellulose (MCC) market. As pharmaceutical companies pursue novel drug formulations and delivery systems, MCC's unique properties-such as its ability to enhance tablet disintegration, improve drug solubility, and act as a binding agent-make it a crucial excipient in formulation processes. The rise of personalized medicine and the need for more efficient drug delivery systems are driving demand for MCC, as it can be tailored to meet the specific requirements of various drug formulations.

The growing demand for pharmaceuticals will significantly promote the microcrystalline cellulose (MCC) segment within the microcrystalline cellulose market. MCC is widely used as an excipient in drug formulations due to its excellent binding, disintegrating, and flow properties, which enhance the efficiency and stability of pharmaceutical products. The increasing prevalence of chronic diseases and the subsequent rise in the need for effective medications are driving pharmaceutical companies to develop new formulations, thereby boosting the demand for high-quality excipients like MCC.

Country/Region-wise Acumens

Will the Increasing Pharmaceutical Industry Accelerate the North American Region for Microcrystalline Cellulose Market?

North America's dominance in the microcrystalline cellulose market. The growing pharmaceutical industry is set to accelerate the microcrystalline cellulose (MCC) market in North America. This region currently dominates the global MCC market, largely due to its strong pharmaceutical sector, which relies heavily on MCC as an excipient in drug formulations. The consistent increase in new drug approvals by the U.S. Food and Drug Administration (FDA)-with 59 in 2018, 48 in 2019, and 53 in 2020-highlights the expanding pharmaceutical landscape and directly drives the demand for MCC. The rising preference for processed foods in North America further contributes to the sustained growth of the MCC market, reinforcing the region's leadership in this industry.

The expansion of the food and beverage industry will accelerate the Microcrystalline Cellulose (MCC) market in North America. The U.S. Department of Agriculture (USDA) highlights that the food processing industry constitutes 16% of the nation's manufacturing sector value, indicating its substantial role in the economy. As consumers increasingly prioritize healthier and more convenient food options, the demand for MCC has surged, particularly as a fat replacer and stabilizer in low-fat products.

Will the Growing Food and Beverage Industry Lead the Asian Pacific Region for Microcrystalline Cellulose Market?

Asia Pacific is rapidly growing in the microcrystalline cellulose market. The growing food and beverage industry is expected to escalate the microcrystalline cellulose (MCC) market in the Asia Pacific region. According to the United Nations Food and Agriculture Organization (FAO), the region is projected to account for 39% of the global food market by 2030, highlighting its significance in the global food landscape. As health consciousness rises among Asian consumers, the demand for MCC as a stabilizer, texturizer, and fat replacer in low-calorie foods aligns perfectly with this trend.

The growing population in the Asia Pacific region will escalate the Microcrystalline Cellulose (MCC) market. The United Nations projects that Asia's population will rise to 5.2 billion by 2050, up from 4.7 billion in 2020, creating a substantial demand for food and pharmaceutical products. This population growth, combined with increasing disposable incomes, is expected to lead to higher consumption of processed foods and pharmaceuticals, where MCC is widely used as an excipient, binder, and stabilizer. As more consumers seek convenient and health-oriented products, the demand for MCC will continue to strengthen, driving market expansion in the region.

Competitive Landscape

The Microcrystalline Cellulose Market is a dynamic and competitive space, characterized by a diverse range of players vying for market share. These players are on the run for solidifying their presence through the adoption of strategic plans such as collaborations, mergers, acquisitions, and political support.

The organizations are focusing on innovating their product line to serve the vast population in diverse regions. Some of the prominent players operating in the market include:

• FMC Corporation
• DuPont de Nemours, Inc.,
• Mingtai Chemical Co., Ltd.
• Asahi Kasei Corporation
• JRS Pharma
• Sigachi Industries
• BNF
• Anhui Sunhere Pharmaceutical Excipients Co., Ltd.
• HPMC
• Medgel

Latest Developments

• In December 2022, JRS PHARMA (J. RETTENMAIER & SOHNE GmbH + Co KG) revealed plans to build a new manufacturing plant in Cedar Rapids, Iowa. The facility, a two-story pre-cast building, will start construction in fall 2022 and begin operations in early 2024, producing Microcrystalline Cellulose products.
• In September 2022, Roquette Freres S.A., a renowned global provider of plant-based ingredients and a top supplier of pharmaceutical and nutraceutical excipients, announced the full acquisition of Crest Cellulose, an excipient manufacturer based in India.

Microcrystalline Cellulose Market, By Category

• Source Type:
• Non-wood-based MCC
• Wood-based MCC
• Application:
• Cosmetics and Personal Care
• Food and Beverages
• Pharmaceuticals
• End User:
• Cosmetics and Personal Care Industry
• Food and Beverage Industry
• Pharmaceutical Industry
• Region:
• North America
• Europe
• Asia-Pacific
• South America
• Middle East & Africa

TABLE OF CONTENTS

1. Introduction

• Market Definition
• Market Segmentation
• Research Methodology

2. Executive Summary

• Key Findings
• Market Overview
• Market Highlights

3. Market Overview

• Market Size and Growth Potential
• Market Trends
• Market Drivers
• Market Restraints
• Market Opportunities
• Porter's Five Forces Analysis

4.Microcrystalline Cellulose Market, By Source Type

• Non-wood-based MCC
• Wood-based MCC

5. Microcrystalline Cellulose Market, By Application

• Cosmetics and Personal Care
• Food and Beverages
• Pharmaceuticals

6. Microcrystalline Cellulose Market, By End User

• Cosmetics and Personal Care Industry
• Food and Beverage Industry
• Pharmaceutical Industry

7. Regional Analysis

• North America
• United States
• Canada
• Mexico
• Europe
• United Kingdom
• Germany
• France
• Italy
• Asia-Pacific
• China
• Japan
• India
• Australia
• Latin America
• Brazil
• Argentina
• Chile
• Middle East and Africa
• South Africa
• Saudi Arabia
• UAE

8. Market Dynamics

• Market Drivers
• Market Restraints
• Market Opportunities
• Impact of COVID-19 on the Market

9. Competitive Landscape

• Key Players
• Market Share Analysis

10. Company Profiles

• Wei Ming Pharmaceutical Co., Ltd. (China)
• Juku Orchem Private Limited (India)
• Sigachi (Japan)
• BLANVER (China)
• Anhui Sunhere Pharmaceutical Group Co., Ltd. (China)
• Roquette Freres (France)
• DuPont de Nemours, Inc. (US)
• Ashland Global Holdings Inc. (US)
• Borregaard ASA (Norway)
• Imerys S.A. (France)

11. Market Outlook and Opportunities

• Emerging Technologies
• Future Market Trends
• Investment Opportunities

12. Appendix

• List of Abbreviations
• Sources and References